T2 Biosystems Garners $15,000,000 Series C Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7f799d77-df7c-4c99-aaed-0cbe707d8c98&Preview=1 -
Date
5/25/2010 -
Company Name
T2 Biosystems -
Mailing Address
286 Cardinal Medeiros Avenue Cambridge, MA 02141 -
Company Description
T2 Biosystems is a newly formed diagnostics company ushering in a new wave of innovative products to improve medical decision-making and treatment. Our proprietary biosensor technology was invented by a team of world-renowned scientists at MIT and Massachusetts General Hospital. Using this technology, we are developing a range of diagnostic products to impact a variety of health care settings; from centralized testing laboratories to point of care. -
Website
http://www.t2biosystems.com -
Transaction Type
Venture Equity -
Transaction Amount
$15,000,000 -
Transaction Round
Series C -
Proceeds Purposes
Proceeds from the financing will be usedto accelerate the development and commercialization of T2 Biosystems’ next generation diagnosticplatform for use in the decentralized setting. -
M&A Terms
-
Venture Investor
Physic Ventures -
Venture Investor
Arcus Ventures -
Venture Investor
Polaris Venture Partners -
Venture Investor
Flybridge Capital Partners -
Venture Investor
WS Investment -
Venture Investor
Flagship Ventures -
Venture Investor
Partners HealthCare System
